Found 49 matching trials
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age PHASE3 The purpose of this study is to evaluate the immunogenicity, safety, and re...
Show More Location
Pinnacle Research Group-409 E 10th St
Learn More & Join Trial
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age PHASE1 The purpose of this study is to evaluate the safety and immunogenicity of d...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of IVX-A12 in Healthy Older Adults PHASE1 The main purpose of this study is to evaluate the safety and immunogenicity...
Show More Learn More & Join Trial
V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002) PHASE2 This study evaluated the safety, tolerability, and efficacy of the cytomega...
Show More Location
Alabama Clinical Therapeutics ( Site 0025)
Learn More & Join Trial
Evaluating New Formulation of Therapeutic HSV-2 Vaccine PHASE2 This study evaluates the reduction in viral shedding after vaccination with...
Show More Location
University of Alabama-Birmingham
Learn More & Join Trial
First Time in Human Study of Long Acting VH4524184 Formulations PHASE1 The purpose of this study is to identify 1 or more doses of parenterally ad...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone PHASE2 To address the question of the comparison of two courses of Vivitrol with d...
Show More Location
Federal Medical Research Center for Psychiatry and Narcology (FMRC)
Learn More & Join Trial
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination PHASE3 The purpose of this phase 3 multicenter, randomized, double-blind, placebo-...
Show More Status
Active Not Recruiting
Location
Alliance for Multispecialty Research, LLC
Learn More & Join Trial
Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005) PHASE2 The purpose of this study is to investigate immunogenicity and safety of Me...
Show More Learn More & Join Trial
TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278 PHASE1 The purpose of this study is to examine the safety, local tolerability and ...
Show More Location
Multiple Locations
Learn More & Join Trial